使用WesternBright Quantum ECL 增強型化學發(fā)光底物客戶文章
瀏覽次數:1279 發(fā)布日期:2014-2-11
來源:本站 僅供參考,謝絕轉載,否則責任自負
美國Advansta公司,全球頂級的ECL發(fā)光液制造商;以超越傳統(tǒng)的靈敏度,引領行業(yè)的品質標準;100%美國原裝進口!
- Fiszer, A., Olejniczak, M., Galka-Marciniak, P., Mykowska, A. & Krzyzosiak, W. J. Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression. Nucleic Acids Research (2013). doi:10.1093/nar/gkt825
- He, P., Ng, B. G., Losfeld, M.-E., Zhu, W. & Freeze, H. H. Identification of intercellular cell adhesion molecule 1 (ICAM-1) as a hypoglycosylation marker in congenital disorders of glycosylation cells. The Journal of Biological Chemistry 287, 18210–18217 (2012).
- Kenneth, K. W. T., Daniel, C. P., X.G., C. & L.W., F. Volasertib (BI 6727), a novel polo-like kinase inhibitor, reverses ABCB1 and ABCG2-mediated multidrug resistance in cancer cells. Journal of Cancer Therapeutics and Research 2, 13 (2013).
- Kozlowska, E., Krzyzosiak, W. J. & Koscianska, E. Regulation of Huntingtin gene expression by miRNA-137, -214, -148a, and their respective isomiRs. International Journal of Molecular Sciences 14, 16999–7016 (2013).
- Kumar, P. et al. The MUC1 extracellular domain subunit is found in nuclear speckles and associates with spliceosomes. PloS One 7, e42712 (2012).
- Miller, G. D., Woessner, D. W., Sirch, M. J. & Lim, C. S. Multi-domain targeting of BCR-ABL by disruption of oligomerization and tyrosine kinase inhibition: towards eradication of CML. Molecular Pharmaceutics (2013). doi:10.1021/mp400323c.
- Thomasy, S. M., Morgan, J. T., Wood, J. A., Murphy, C. J. & Russell, P. Substratum Stiffness and Latrunculin B Modulate the Gene Expression of the Mechanotransducers YAP and TAZ in Human Trabecular Meshwork Cells. Experimental Eye Research 113, 66–73 (2013).
- To, K. K. W., Ren, S. X., Wong, C. C. M. & Cho, C. H. Reversal of ABCG2-mediated multidrug resistance by human cathelicidin and its analogs in cancer cells. Peptides 40C, 13–21 (2012).